{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-067531","form_type":"8-K","ticker":"CTMX","cik":"0001501989","company_name":"CytomX Therapeutics, Inc.","filed_at":"2023-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.289939+00:00","generated_at":"2026-06-18T05:26:12.721758+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CytomX says SVB exposure immaterial; cash near FDIC limit, $917K letter of credit","bullets":["Operating cash at SVB at or near FDIC-insured limit of $250,000.","Standby letter of credit under office lease: ~$917,000 deposited at SVB.","Third-party investments held at outside custodians, not directly exposed to SVB.","Company does not consider SVB liquidity concern material to its operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-067531","json":"https://secwatch.observer/filing/0001193125-23-067531.json","markdown":"https://secwatch.observer/filing/0001193125-23-067531.md","text":"https://secwatch.observer/filing/0001193125-23-067531.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501989/000119312523067531/0001193125-23-067531-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501989/000119312523067531/d280737d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T05:26:12.721758+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}